Business
Metatron (MRNJ) Integrates Secure Chat App, Marijuana/CBD App and Bitweed™ Bitcoin Payment Platform with Sanguine Biotech (SGUI)
Metatron (MRNJ) Integrates Secure Chat App, Marijuana/CBD App and Bitweed™ Bitcoin Payment Platform with Sanguine Biotech (SGUI).
About this update from Metatron Inc
[{"type":"text","content":"\n\n DOVER, Del., Dec. 13, 2017 (GLOBE NEWSWIRE) -- Metatron (OTC:MRNJ), a technology pioneer specializing in the accelerated release of over 2000 apps including Cannabis based, CBD, and Vaporized™ secure chat apps via iTunes and Google Play, is pleased to report the final stage development of Bitweed™, a cryptocurrency transaction and tracking app for Marijuana dispensaries and consumers that we expect to evolve into its own token/coin.\n Sanguine Biotech Corp (SGUI) now distributes the Metatron developed and recent updated Cannaboids™ and Vaporized Secure Chat app under its own iTunes account with Google Play soon to follow. The digital currency market's total value surpassed $500 billion for the first time, smashing through this milestone amid signs of growing interest in cryptocurrencies. The number of accounts on Coinbase stood at 13.3 million at the end of November, a more than 100% increase from the 5.5 million that existed in January, according to the New York Times. “Bitcoin has risen over 1500% this year, about 85% in the last few weeks, trading Bitcoin Futures and Etherium up 15% yesterday..this Blockchain revolution may make look the internet and app booms seem like firecrackers. Cannabis is legal in about 29 states, and Canada just made recreational Marijuana legal, both multi-billion dollar Crypto and Cannabis industries deserve safe and efficient payment solutions that consumers should easily understand. Right now most people need someone to show them how to set up a simple secure crypto walled. We expect Bitweed™ and upcoming products to eventually evolve into its own cryptocoin and solve this glaring market need,” said CEO Joe Riehl Sanguine Corporation (SGUI)  (through its subsidiary, SGN LifeSciences), is engaged in discovering, developing and commercializing novel biotechnologies. The company is focused on the development and commercialization of perfluorocarbon based therapeutic oxygen carriers. The Company’s core product, PHER-02, is a perfluorocarbon emulsion. Our two companies plan to conduct a shared roll-out of mobile applications geared to solve issues in the cannabis payment space using Blockchain technology and Bitcoin options. These apps will be marketed under Cannaboids™ (www.cannaboids.com), and Bitweed™ brands while Sanguine provides...